Mesoporous silica nanoparticles synthesized from liquid crystal display manufacturing extracts as a potential candidate for a drug delivery carrier: Evaluation of their safety and biocompatibility

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 3833-3842

  Lin, Yu Chih ^a   Lin, Liang Yi ^b   Gao, Ming Yi ^a   Fang, Yi Ping ^a  

^a YUANPEI UNIVERSITY   (Taiwan)

^b NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

Biocompatibility; Drug delivery carrier; Mesoporous silica nanoparticles (MSNs); Safety; Waste recycle

Indexed keywords

CAMPTOTHECIN; LACTATE DEHYDROGENASE; MESOPOROUS SILICA NANOPARTICLE; METHOTREXATE; NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DISPLAY SYSTEM; DRUG DELIVERY SYSTEM; ENZYME ASSAY; ENZYME RELEASE; ERYTHROCYTE; FILTRATION; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROLYSIS; HYDROPHOBICITY; LIQUID CRYSTAL DISPLAY; PHYSICAL CHEMISTRY; SAFETY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

BIOCOMPATIBILITY; DRUG DELIVERY CARRIER; MESOPOROUS SILICA NANOPARTICLES (MSNS); SAFETY; WASTE RECYCLE;

CELL LINE; CELL SURVIVAL; COMPUTER TERMINALS; FEASIBILITY STUDIES; HUMANS; INDUSTRIAL WASTE; LIQUID CRYSTALS; NANOCAPSULES; NANOPORES; PARTICLE SIZE; POROSITY; RECYCLING; SILICON DIOXIDE;

EID: 84885770552     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S50991     Document Type: Article

References (33)

1. Tang F, Li L, Chen D. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater. 2012;24(12): 1504-1534.
2. Vallet-Regi M, Rámila A, del Real RP, Pérez-Pariente J. A new property of MCM-41: drug delivery system. Chem Mater. 2001;13(2):308-311.
3. Huo Q, Leon R, Petroff PM, Stucky GD. Mesostructure design with gemini surfactants: supercage formation in a three-dimensional hexagonal array. Science. 1995;268(5215):1324-1327.
4. Zhao D, Feng J, Huo Q, et al. Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Science. 1998;279(5350):548-552.
5. Bagshaw SA, Prouzet E, Pinnavaia TJ. Templating of mesoporous molecular sieves by nonionic polyethylene oxide surfactants. Science. 1995;269(5228):1242-1244.
6. Inagaki S, Fukushima Y, Kuroda K. Synthesis of highly ordered mesoporous materials from a layered polysilicate. J Chem Soc Chem Commun. 1993;8:680-682.
7. Beck JS, Vartuli JC, Roth WJ, et al. A new family of mesoporous molecular sieves prepared with liquid crystal templates. J Am Chem Soc. 1992;114(27):10834-10843.
8. Lin HP, Cheng S, Mou CY. Mesoporous molecular sieves MCM-41 with a hollow tubular morphology. Chem Mater. 1998;10(2):581-589.
9. Choi CL, Park M, Lee DH, Kim IE, Park BY, Choi J. Salt-thermal zeolitization of fly ash. Environ Sci Technol. 2001;35(13):2812-2816.
10. Chang HL, Chun CM, Aksay IA, Shih WH. Conversion of fly ash into mesoporous aluminosilicate. Ind Eng Chem Res. 1999;38(3): 973-977.
11. Hui KS, Chao CY. Synthesis of MCM-41 from coal fly ash by a green approach: influence of synthesis pH. J Hazard Mater. 2006;137(2): 1135-1148.
12. Bhagiyalakshmi M, Yun LJ, Anuradha R, Jang HT. Utilization of rice husk ash as silica source for the synthesis of mesoporous silicas and their application to CO2 adsorption through TREN/TEPA grafting. J Hazard Mater. 2010;175(1-3):928-938.
13. Cho Y, Shi R, Borgens RB, Ivanisevic A. Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death. Nanomedicine (Lond). 2008;3(4):507-519.
14. Popat A, Hartono SB, Stahr F, Liu J, Qiao SZ, Qing Max Lu G. Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers. Nanoscale. 2011;3(7):2801-2818.
15. Shi J, Votruba AR, Farokhzad OC, Langer R. Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett. 2010;10(9):3223-3230.
16. Arruebo M. Drug delivery from structured porous inorganic materials. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012;4(1):16-30.
17. Climent E, Bernardos A, Martínez-Máñez R, et al. Controlled delivery systems using antibody-capped mesoporous nanocontainers. J Am Chem Soc. 2009;131(39):14075-14080.
18. Aznar E, Marcos MD, Martínez-Máñez R, et al. pH- and photo-switched release of guest molecules from mesoporous silica supports. J Am Chem Soc. 2009;131(19):6833-6843.
19. Lin LY, Kuo JT, Bai H. Silica materials recovered from photonic industrial waste powder: its extraction, modification, characterization and application. J Hazard Mater. 2011;192(1):255-262.
20. Lin LY, Bai H. Efficient method for recycling silica materials from waste powder of the photonic industry. Environ Sci Technol. 2013;47(9):4636-4643.
21. Al-Attar L, Dyer A, Harjula R. Uptake of radionuclides on microporous and layered ion exchange materials. J Mater Chem. 2003;13:2963-2968.
22. Bore MT, Rathod SB, Ward TL, Datye AK. Hexagonal mesostructure in powders produced by evaporation-induced self-assembly of aerosols from aqueous tetraethoxysilane solutions. Langmuir. 2003;19(2):256-264.
23. Chandrasekar G, You K, Ahn J, Ahn W. Synthesis of hexagonal and cubic mesoporous silica using power plant bottom ash. Microporous Mesoporous Mater. 2008;111(1-3):455-462.
24. Lin YS, Haynes CL. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. J Am Chem Soc. 2010;132(13):4834-4842.
25. He X, Nie H, Wang K, Tan W, Wu X, Zhang P. In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles. Anal Chem. 2008;80(24):9597-9603.
26. Napierska D, Thomassen LC, Rabolli V, et al. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small. 2009;5(7):846-853.
27. Koster VS, Kuks PFM, Lange R, Talsma H. Particle size in parenteral fat emulsions, what are the true limitations? Int J Pharm. 1996;134(1-2):235-238.
28. Zhao Y, Sun X, Zhang G, Trewyn BG, Slowing II, Lin VS. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. ACS Nano. 2011;5(2):1366-1375.
29. Murashov V, Harper M, Demchuk E. Impact of silanol surface density on the toxicity of silica aerosols measured by erythrocyte haemolysis. J Occup Environ Hyg. 2006;3(12):718-723.
30. Lin YS, Haynes CL. Synthesis and characterization of biocompatible and size-tunable multifunctional porous silica nanoparticles. Chem Mater. 2009;21(17):3979-3986.
31. Cunha KS, Reguly ML, Graf U, Rodrigues de Andrade HH. Comparison of camptothecin derivatives presently in clinical trials: genotoxic potency and mitotic recombination. Mutagenesis. 2002;17(2):141-147.
32. Lu J, Liong M, Zink JI, Tamanoi F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small. 2007;3(8):1341-1346.
33. Hon YY, Evans WE. Making TDM work to optimize cancer chemotherapy: a multidisciplinary team approach. Clin Chem. 1998;44(2):388-400.